{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:44:54Z","timestamp":1760028294422,"version":"3.37.3"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T00:00:00Z","timestamp":1626912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T00:00:00Z","timestamp":1626912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Although antipsychotics, such as olanzapine, are effective in the management of psychiatric conditions, some patients experience excessive antipsychotic-induced weight gain (AIWG). To illuminate pathways underlying AIWG, we compared baseline blood gene expression profiles in two cohorts of mice that were either prone (AIWG-P) or resistant (AIWG-R) to weight gain in response to olanzapine treatment for two weeks. We found that transcripts elevated in AIWG-P mice relative to AIWG-R are enriched for high-confidence transcriptional targets of numerous inflammatory and immunomodulatory signaling nodes. Moreover, these nodes are themselves enriched for genes whose disruption in mice is associated with reduced body fat mass and slow postnatal weight gain. In addition, we identified gene expression profiles in common between our mouse AIWG-P gene set and an existing human AIWG-P gene set whose regulation by immunomodulatory transcription factors is highly conserved between species. Finally, we identified striking convergence between mouse AIWG-P transcriptional regulatory networks and those associated with body weight and body mass index in humans. We propose that immunomodulatory transcriptional networks drive AIWG, and that these networks have broader conserved roles in whole body-metabolism.<\/jats:p>","DOI":"10.1038\/s41398-021-01528-y","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T14:03:24Z","timestamp":1626962604000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Conserved immunomodulatory transcriptional networks underlie antipsychotic-induced weight gain"],"prefix":"10.1038","volume":"11","author":[{"given":"Rizaldy C.","family":"Zapata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0340-3270","authenticated-orcid":false,"given":"Besma S.","family":"Chaudry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariela Lopez","family":"Valencia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinghong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott A.","family":"Ochsner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil J.","family":"McKenna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0516-7937","authenticated-orcid":false,"given":"Olivia","family":"Osborn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,22]]},"reference":[{"key":"1528_CR1","doi-asserted-by":"publisher","first-page":"e94112","DOI":"10.1371\/journal.pone.0094112","volume":"9","author":"M Bak","year":"2014","unstructured":"Bak M, Fransen A, Janssen J, van Os J, Drukker M. Almost all antipsychotics result in weight gain: a meta-analysis. PLoS ONE. 2014;9:e94112.","journal-title":"PLoS ONE"},{"key":"1528_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41537-018-0053-9","volume":"4","author":"J Spertus","year":"2018","unstructured":"Spertus J, Horvitz-Lennon M, Abing H, Normand SL. Risk of weight gain for specific antipsychotic drugs: a meta-analysis. NPJ Schizophr. 2018;4:12.","journal-title":"NPJ Schizophr"},{"key":"1528_CR3","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.phrs.2015.07.022","volume":"101","author":"LE Rojo","year":"2015","unstructured":"Rojo LE, Gaspar PA, Silva H, Risco L, Arena P, Cubillos-Robles K, et al. Metabolic syndrome and obesity among users of second generation antipsychotics: A global challenge for modern psychopharmacology. Pharm Res. 2015;101:74\u201385.","journal-title":"Pharm Res"},{"key":"1528_CR4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4088\/JCP.7075su1c.05","volume":"70","author":"JW Newcomer","year":"2009","unstructured":"Newcomer JW. Comparing the safety and efficacy of atypical antipsychotics in psychiatric patients with comorbid medical illnesses. J Clin Psychiatry. 2009;70:30\u20136.","journal-title":"J Clin Psychiatry"},{"key":"1528_CR5","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/j.1524-6175.2006.04751.x","volume":"8","author":"MR Wofford","year":"2006","unstructured":"Wofford MR, King DS, Harrell TK. Drug-induced metabolic syndrome. J Clin Hypertens. 2006;8:114\u20139.","journal-title":"J Clin Hypertens"},{"key":"1528_CR6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2147\/PROM.S42735","volume":"5","author":"PM Haddad","year":"2014","unstructured":"Haddad PM, Brain C, Scott J. Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies. Patient Relat Outcome Meas. 2014;5:43\u201362.","journal-title":"Patient Relat Outcome Meas"},{"key":"1528_CR7","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1093\/schbul\/sbw058","volume":"42","author":"JP Zhang","year":"2016","unstructured":"Zhang JP, Lencz T, Zhang RX, Nitta M, Maayan L, John M, et al. Pharmacogenetic associations of antipsychotic drug-related weight gain: a systematic review and meta-analysis. Schizophr Bull. 2016;42:1418\u201337.","journal-title":"Schizophr Bull"},{"key":"1528_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1517\/17425255.2011.532787","volume":"7","author":"JP Zhang","year":"2011","unstructured":"Zhang JP, Malhotra AK. Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction. Expert Opin Drug Metab Toxicol. 2011;7:9\u201337.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"1528_CR9","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.2147\/NDT.S209284","volume":"15","author":"L Citrome","year":"2019","unstructured":"Citrome L, McEvoy JP, Todtenkopf MS, McDonnell D, Weiden PJ. A commentary on the efficacy of olanzapine for the treatment of schizophrenia: the past, present, and future. Neuropsychiatr Dis Treat. 2019;15:2559\u201369.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"1528_CR10","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1586\/ern.10.85","volume":"10","author":"L Maayan","year":"2010","unstructured":"Maayan L, Correll CU. Management of antipsychotic-related weight gain. Expert Rev Neurother. 2010;10:1175\u2013200.","journal-title":"Expert Rev Neurother"},{"key":"1528_CR11","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1080\/10673220701679838","volume":"15","author":"TC Manschreck","year":"2007","unstructured":"Manschreck TC, Boshes RA. The CATIE schizophrenia trial: results, impact, controversy. Harv Rev Psychiatry. 2007;15:245\u201358.","journal-title":"Harv Rev Psychiatry"},{"key":"1528_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.brainres.2018.05.014","volume":"1695","author":"KT Nakhate","year":"2018","unstructured":"Nakhate KT, Subhedar NK, Kokare DM. A role of neuropeptide CART in hyperphagia and weight gain induced by olanzapine treatment in rats. Brain Res. 2018;1695:45\u201352.","journal-title":"Brain Res"},{"key":"1528_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00023210-200519001-00001","volume":"19","author":"JW Newcomer","year":"2005","unstructured":"Newcomer JW. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs. 2005;19:1\u201393.","journal-title":"CNS Drugs"},{"key":"1528_CR14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4103\/0019-5545.31617","volume":"48","author":"S Jain","year":"2006","unstructured":"Jain S, Bhargava M, Gautam S. Weight gain with olanzapine: Drug, gender or age? Indian J Psychiatry. 2006;48:39\u201342.","journal-title":"Indian J Psychiatry"},{"key":"1528_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07684-y","volume":"9","author":"A Perez-Gomez","year":"2018","unstructured":"Perez-Gomez A, Carretero M, Weber N, Peterka V, To A, Titova V, et al. A phenotypic Caenorhabditis elegans screen identifies a selective suppressor of antipsychotic-induced hyperphagia. Nat Commun. 2018;9:5272.","journal-title":"Nat Commun"},{"key":"1528_CR16","doi-asserted-by":"publisher","first-page":"112859","DOI":"10.1016\/j.physbeh.2020.112859","volume":"220","author":"RC Zapata","year":"2020","unstructured":"Zapata RC, Osborn O. Susceptibility of male wild type mouse strains to antipsychotic-induced weight gain. Physiol Behav. 2020;220:112859.","journal-title":"Physiol Behav"},{"key":"1528_CR17","doi-asserted-by":"publisher","first-page":"e115225","DOI":"10.1371\/journal.pone.0115225","volume":"9","author":"AP Morgan","year":"2014","unstructured":"Morgan AP, Crowley JJ, Nonneman RJ, Quackenbush CR, Miller CN, Ryan AK, et al. The antipsychotic olanzapine interacts with the gut microbiome to cause weight gain in mouse. PLoS ONE. 2014;9:e115225.","journal-title":"PLoS ONE"},{"key":"1528_CR18","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9:357\u20139.","journal-title":"Nat Methods"},{"key":"1528_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinforma. 2011;12:323.","journal-title":"BMC Bioinforma"},{"key":"1528_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41537-019-0075-y","volume":"5","author":"B Crespo-Facorro","year":"2019","unstructured":"Crespo-Facorro B, Prieto C, Sainz J. Altered gene expression in antipsychotic-induced weight gain. NPJ Schizophr. 2019;5:7.","journal-title":"NPJ Schizophr"},{"key":"1528_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/978-1-60761-175-2_7","volume":"563","author":"H Mi","year":"2009","unstructured":"Mi H, Thomas P. PANTHER pathway: an ontology-based pathway database coupled with data analysis tools. Methods Mol Biol. 2009;563:123\u201340.","journal-title":"Methods Mol Biol"},{"key":"1528_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41597-019-0193-4","volume":"6","author":"SA Ochsner","year":"2019","unstructured":"Ochsner SA, Abraham D, Martin K, Ding W, McOwiti A, Kankanamge W, et al. The signaling pathways project, an integrated \u2018omics knowledgebase for mammalian cellular signaling pathways. Sci Data. 2019;6:252.","journal-title":"Sci Data"},{"key":"1528_CR23","doi-asserted-by":"publisher","first-page":"314.","DOI":"10.1038\/s41597-020-00628-6","volume":"7","author":"SA Ochsner","year":"2020","unstructured":"Ochsner SA, Pillich RT, McKenna NJ.Consensus transcriptional regulatory networks of coronavirus-infected human cells. Sci Data. 2020;7:314.","journal-title":"Sci Data"},{"key":"1528_CR24","doi-asserted-by":"publisher","first-page":"e46255","DOI":"10.15252\/embr.201846255","volume":"19","author":"S Oki","year":"2018","unstructured":"Oki S, Ohta T, Shioi G, Hatanaka H, Ogasawara O, Okuda Y. et al. ChIP-Atlas: a data-mining suite powered by full integration of public ChIP-seq data. EMBO Rep. 2018;19:e46255","journal-title":"EMBO Rep"},{"key":"1528_CR25","doi-asserted-by":"publisher","first-page":"D419","DOI":"10.1093\/nar\/gky1038","volume":"47","author":"H Mi","year":"2019","unstructured":"Mi H, Muruganujan A, Ebert D, Huang X, Thomas PD. PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools. Nucleic Acids Res. 2019;47:D419\u2013D26.","journal-title":"Nucleic Acids Res"},{"key":"1528_CR26","doi-asserted-by":"publisher","first-page":"980547","DOI":"10.1155\/2014\/980547","volume":"2014","author":"Z Khitan","year":"2014","unstructured":"Khitan Z, Harsh M, Sodhi K, Shapiro JI, Abraham NG. HO-1 Upregulation attenuates adipocyte dysfunction, obesity, and isoprostane levels in mice fed high fructose diets. J Nutr Metab. 2014;2014:980547.","journal-title":"J Nutr Metab"},{"key":"1528_CR27","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s00125-017-4228-0","volume":"60","author":"JM Moreno-Navarrete","year":"2017","unstructured":"Moreno-Navarrete JM, Ortega F, Rodr\u00edguez A, Latorre J, Becerril S, Sabater-Masdeu M, et al. HMOX1 as a marker of iron excess-induced adipose tissue dysfunction, affecting glucose uptake and respiratory capacity in human adipocytes. Diabetologia 2017;60:915\u201326.","journal-title":"Diabetologia"},{"key":"1528_CR28","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1002\/oby.21956","volume":"25","author":"JM Moreno-Navarrete","year":"2017","unstructured":"Moreno-Navarrete JM, Rodr\u00edguez A, Ortega F, Becerril S, Girones J, Sabater-Masdeu M, et al. Heme biosynthetic pathway is functionally linked to adipogenesis via mitochondrial respiratory activity. Obes. (Silver Spring). 2017;25:1723\u201333.","journal-title":"Obes. (Silver Spring)."},{"key":"1528_CR29","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1126\/science.281.5381.1309","volume":"281","author":"DR Green","year":"1998","unstructured":"Green DR, Reed JC. Mitochondria and apoptosis. Science 1998;281:1309\u201312.","journal-title":"Science"},{"key":"1528_CR30","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0065-2571(72)90013-1","volume":"10","author":"CR Rossi","year":"1972","unstructured":"Rossi CR, Alexandre A, Carignani G, Siliprandi N. The role of mitochondrial adenine nucleotide pool on the regulation of fatty acid and -ketoglutarate oxidation. Adv Enzym Regul. 1972;10:171\u201386.","journal-title":"Adv Enzym Regul"},{"key":"1528_CR31","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/nature07976","volume":"458","author":"R Singh","year":"2009","unstructured":"Singh R, Kaushik S, Wang Y, Xiang Y, Novak I, Komatsu M, et al. Autophagy regulates lipid metabolism. Nature 2009;458:1131\u20135.","journal-title":"Nature"},{"key":"1528_CR32","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.cell.2006.01.016","volume":"124","author":"S Wullschleger","year":"2006","unstructured":"Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell 2006;124:471\u20138.","journal-title":"Cell"},{"key":"1528_CR33","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature05485","volume":"444","author":"GS Hotamisligil","year":"2006","unstructured":"Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006;444:860\u20137.","journal-title":"Nature"},{"key":"1528_CR34","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/nm.2627","volume":"18","author":"O Osborn","year":"2012","unstructured":"Osborn O, Olefsky JM. The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med. 2012;18:363\u201374.","journal-title":"Nat Med"},{"key":"1528_CR35","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1152\/physrev.2001.81.2.807","volume":"81","author":"JM Kyriakis","year":"2001","unstructured":"Kyriakis JM, Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev. 2001;81:807\u201369.","journal-title":"Physiol Rev"},{"key":"1528_CR36","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1128\/MCB.25.4.1215-1227.2005","volume":"25","author":"R Ferreira","year":"2005","unstructured":"Ferreira R, Ohneda K, Yamamoto M, Philipsen S. GATA1 function, a paradigm for transcription factors in hematopoiesis. Mol Cell Biol. 2005;25:1215\u201327.","journal-title":"Mol Cell Biol"},{"key":"1528_CR37","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0092-8674(00)80076-8","volume":"86","author":"C Porcher","year":"1996","unstructured":"Porcher C, Swat W, Rockwell K, Fujiwara Y, Alt FW, Orkin SH. The T cell leukemia oncoprotein SCL\/tal-1 is essential for development of all hematopoietic lineages. Cell 1996;86:47\u201357.","journal-title":"Cell"},{"key":"1528_CR38","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.3389\/fimmu.2018.02542","volume":"9","author":"E Platanitis","year":"2018","unstructured":"Platanitis E, Decker T. Regulatory networks involving STATs, IRFs, and NFkappaB in inflammation. Front Immunol. 2018;9:2542.","journal-title":"Front Immunol"},{"key":"1528_CR39","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.cyto.2010.12.019","volume":"54","author":"J Tsukada","year":"2011","unstructured":"Tsukada J, Yoshida Y, Kominato Y, Auron PE. The CCAAT\/enhancer (C\/EBP) family of basic-leucine zipper (bZIP) transcription factors is a multifaceted highly-regulated system for gene regulation. Cytokine 2011;54:6\u201319.","journal-title":"Cytokine"},{"key":"1528_CR40","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1080\/01902140490276320","volume":"30","author":"DA Groneberg","year":"2004","unstructured":"Groneberg DA, Witt H, Adcock IM, Hansen G, Springer J. Smads as intracellular mediators of airway inflammation. Exp Lung Res. 2004;30:223\u201350.","journal-title":"Exp Lung Res"},{"key":"1528_CR41","doi-asserted-by":"publisher","first-page":"104551","DOI":"10.1016\/j.psyneuen.2019.104551","volume":"113","author":"H Wei","year":"2020","unstructured":"Wei H, Zapata RC, Lopez-Valencia M, Aslanoglou D, Farino ZJ, Benner V, et al. Dopamine D2 receptor signaling modulates pancreatic beta cell circadian rhythms. Psychoneuroendocrinology 2020;113:104551.","journal-title":"Psychoneuroendocrinology"},{"key":"1528_CR42","doi-asserted-by":"publisher","first-page":"17582","DOI":"10.1073\/pnas.0909733106","volume":"106","author":"AY So","year":"2009","unstructured":"So AY, Bernal TU, Pillsbury ML, Yamamoto KR, Feldman BJ. Glucocorticoid regulation of the circadian clock modulates glucose homeostasis. Proc Natl Acad Sci USA. 2009;106:17582\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1528_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11807","volume":"7","author":"A Shostak","year":"2016","unstructured":"Shostak A, Ruppert B, Ha N, Bruns P, Toprak UH, ICGC MMML-Seq P, et al. MYC\/MIZ1-dependent gene repression inversely coordinates the circadian clock with cell cycle and proliferation. Nat Commun. 2016;7:11807.","journal-title":"Nat Commun"},{"key":"1528_CR44","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.cell.2006.06.050","volume":"126","author":"X Yang","year":"2006","unstructured":"Yang X, Downes M, Yu RT, Bookout AL, He W, Straume M, et al. Nuclear receptor expression links the circadian clock to metabolism. Cell 2006;126:801\u201310.","journal-title":"Cell"},{"key":"1528_CR45","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1182\/blood-2005-01-0358","volume":"106","author":"S Gery","year":"2005","unstructured":"Gery S, Gombart AF, Yi WS, Koeffler C, Hofmann WK, Koeffler HP. Transcription profiling of C\/EBP targets identifies Per2 as a gene implicated in myeloid leukemia. Blood 2005;106:2827\u201336.","journal-title":"Blood"},{"key":"1528_CR46","doi-asserted-by":"publisher","first-page":"D704","DOI":"10.1093\/nar\/gkz997","volume":"48","author":"KA Shefchek","year":"2020","unstructured":"Shefchek KA, Harris NL, Gargano M, Matentzoglu N, Unni D, Brush M, et al. The Monarch Initiative in 2019: an integrative data and analytic platform connecting phenotypes to genotypes across species. Nucleic Acids Res. 2020;48:D704\u2013D15.","journal-title":"Nucleic Acids Res"},{"key":"1528_CR47","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s10592-018-1072-9","volume":"19","author":"V Mu\u00f1oz-Fuentes","year":"2018","unstructured":"Mu\u00f1oz-Fuentes V, Cacheiro P, Meehan TF, Aguilar-Pimentel JA, Brown S, Flenniken AM, et al. The International Mouse Phenotyping Consortium (IMPC): a functional catalogue of the mammalian genome that informs conservation. Conserv Genet. 2018;19:995\u20131005.","journal-title":"Conserv Genet"},{"key":"1528_CR48","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s00335-012-9425-z","volume":"23","author":"MR Laughlin","year":"2012","unstructured":"Laughlin MR, Lloyd KC, Cline GW, Wasserman DH. NIH Mouse Metabolic Phenotyping Centers: the power of centralized phenotyping. Mamm Genome. 2012;23:623\u201331.","journal-title":"Mamm Genome"},{"key":"1528_CR49","doi-asserted-by":"publisher","first-page":"10925","DOI":"10.1073\/pnas.89.22.10925","volume":"89","author":"C Le van Kim","year":"1992","unstructured":"Le van Kim C, Mouro I, Ch\u00e9rif-Zahar B, Raynal V, Cherrier C, Cartron JP, et al. Molecular cloning and primary structure of the human blood group RhD polypeptide. Proc Natl Acad Sci USA. 1992;89:10925\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1528_CR50","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.chom.2013.03.006","volume":"13","author":"S Amini-Bavil-Olyaee","year":"2013","unstructured":"Amini-Bavil-Olyaee S, Choi YJ, Lee JH, Shi M, Huang IC, Farzan M, et al. The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry. Cell Host Microbe. 2013;13:452\u201364.","journal-title":"Cell Host Microbe"},{"key":"1528_CR51","doi-asserted-by":"publisher","first-page":"15125","DOI":"10.1073\/pnas.011593298","volume":"98","author":"KC Chin","year":"2001","unstructured":"Chin KC, Cresswell P. Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus. Proc Natl Acad Sci USA. 2001;98:15125\u201330.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1528_CR52","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1039\/C7MT00341B","volume":"10","author":"K Honarmand Ebrahimi","year":"2018","unstructured":"Honarmand Ebrahimi K. A unifying view of the broad-spectrum antiviral activity of RSAD2 (viperin) based on its radical-SAM chemistry. Metallomics. 2018;10:539\u201352.","journal-title":"Metallomics"},{"key":"1528_CR53","doi-asserted-by":"publisher","first-page":"8332","DOI":"10.1128\/JVI.02199-09","volume":"84","author":"D Jiang","year":"2010","unstructured":"Jiang D, Weidner JM, Qing M, Pan XB, Guo H, Xu C, et al. Identification of five interferon-induced cellular proteins that inhibit west nile virus and dengue virus infections. J Virol. 2010;84:8332\u201341.","journal-title":"J Virol"},{"key":"1528_CR54","doi-asserted-by":"publisher","first-page":"17419","DOI":"10.1073\/pnas.1904480116","volume":"116","author":"J Eom","year":"2019","unstructured":"Eom J, Kim JJ, Yoon SG, Jeong H, Son S, Lee JB, et al. Intrinsic expression of viperin regulates thermogenesis in adipose tissues. Proc Natl Acad Sci USA. 2019;116:17419\u201328.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1528_CR55","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1042\/BJ20140644","volume":"466","author":"K Blaszczyk","year":"2015","unstructured":"Blaszczyk K, Olejnik A, Nowicka H, Ozgyin L, Chen YL, Chmielewski S, et al. STAT2\/IRF9 directs a prolonged ISGF3-like transcriptional response and antiviral activity in the absence of STAT1. Biochem J. 2015;466:511\u201324.","journal-title":"Biochem J"},{"key":"1528_CR56","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4049\/jimmunol.2000086","volume":"205","author":"GM Wiedemann","year":"2020","unstructured":"Wiedemann GM, Geary CD, Lau CM, Sun JC. Cutting edge: STAT1-mediated epigenetic control of Rsad2 promotes clonal expansion of antiviral NK cells. J Immunol. 2020;205:21\u20135.","journal-title":"J Immunol"},{"key":"1528_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tig.2013.10.001","volume":"30","author":"PE Love","year":"2014","unstructured":"Love PE, Warzecha C, Li L. Ldb1 complexes: the new master regulators of erythroid gene transcription. Trends Genet. 2014;30:1\u20139.","journal-title":"Trends Genet"},{"key":"1528_CR58","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1128\/MCB.00806-15","volume":"36","author":"GC Han","year":"2016","unstructured":"Han GC, Vinayachandran V, Bataille AR, Park B, Chan-Salis KY, Keller CA, et al. Genome-Wide Organization of GATA1 and TAL1 determined at high resolution. Mol Cell Biol. 2016;36:157\u201372.","journal-title":"Mol Cell Biol"},{"key":"1528_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-43881-5","volume":"9","author":"PV Joseph","year":"2019","unstructured":"Joseph PV, Jaime-Lara RB, Wang Y, Xiang L, Henderson WA. Comprehensive and systematic analysis of gene expression patterns associated with body mass index. Sci Rep. 2019;9:7447.","journal-title":"Sci Rep"},{"key":"1528_CR60","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.metabol.2009.05.020","volume":"58","author":"TL Chang","year":"2009","unstructured":"Chang TL, Chang CJ, Lee WY, Lin MN, Huang YW, Fan K. The roles of ubiquitin and 26S proteasome in human obesity. Metabolism 2009;58:1643\u20138.","journal-title":"Metabolism"},{"key":"1528_CR61","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.immuni.2016.06.020","volume":"45","author":"J Liu","year":"2016","unstructured":"Liu J, Qian C, Cao X. Post-translational modification control of innate immunity. Immunity 2016;45:15\u201330.","journal-title":"Immunity"},{"key":"1528_CR62","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1172\/JCI88876","volume":"127","author":"T McLaughlin","year":"2017","unstructured":"McLaughlin T, Ackerman SE, Shen L, Engleman E. Role of innate and adaptive immunity in obesity-associated metabolic disease. J Clin Invest. 2017;127:5\u201313.","journal-title":"J Clin Invest"},{"key":"1528_CR63","doi-asserted-by":"publisher","first-page":"e1007222","DOI":"10.1371\/journal.pgen.1007222","volume":"14","author":"TJ Baranski","year":"2018","unstructured":"Baranski TJ, Kraja AT, Fink JL, Feitosa M, Lenzini PA, Borecki IB, et al. A high throughput, functional screen of human body mass index GWAS loci using tissue-specific RNAi Drosophila melanogaster crosses. PLoS Genet. 2018;14:e1007222.","journal-title":"PLoS Genet"},{"key":"1528_CR64","doi-asserted-by":"publisher","first-page":"231","DOI":"10.4088\/JCP.v62n0404","volume":"62","author":"BR Basson","year":"2001","unstructured":"Basson BR, Kinon BJ, Taylor CC, Szymanski KA, Gilmore JA, Tollefson GD. Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone. J Clin Psychiatry. 2001;62:231\u20138.","journal-title":"J Clin Psychiatry"},{"key":"1528_CR65","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0920-9964(02)00431-0","volume":"62","author":"J Bobes","year":"2003","unstructured":"Bobes J, Rejas J, Garcia-Garcia M, Rico-Villademoros F, Garc\u00eda-Portilla MP, Fern\u00e1ndez I, et al. Weight gain in patients with schizophrenia treated with risperidone, olanzapine, quetiapine or haloperidol: results of the EIRE study. Schizophr Res. 2003;62:77\u201388.","journal-title":"Schizophr Res"},{"key":"1528_CR66","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.pnpbp.2017.11.004","volume":"82","author":"TSJ Iversen","year":"2018","unstructured":"Iversen TSJ, Steen NE, Dieset I, Hope S, M\u00f8rch R, Gardsjord ES, et al. Side effect burden of antipsychotic drugs in real life - Impact of gender and polypharmacy. Prog Neuropsychopharmacol Biol Psychiatry. 2018;82:263\u201371.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1528_CR67","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.schres.2005.07.014","volume":"80","author":"JP McEvoy","year":"2005","unstructured":"McEvoy JP, Meyer JM, Goff DC, Nasrallah HA, Davis SM, Sullivan L, et al. Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the clinical antipsychotic trials of intervention effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophr Res. 2005;80:19\u201332.","journal-title":"Schizophr Res"},{"key":"1528_CR68","first-page":"573","volume":"25","author":"E Mattiuz","year":"1997","unstructured":"Mattiuz E, Franklin R, Gillespie T, Murphy A, Bernstein J, Chiu A, et al. Disposition and metabolism of olanzapine in mice, dogs, and rhesus monkeys. Drug Metab Dispos. 1997;25:573\u201383.","journal-title":"Drug Metab Dispos"},{"key":"1528_CR69","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2165\/00003088-199937030-00001","volume":"37","author":"JT Callaghan","year":"1999","unstructured":"Callaghan JT, Bergstrom RF, Ptak LR, Beasley CM. Olanzapine. Pharmacokinetic and pharmacodynamic profile. Clin. Pharmacokinet. 1999;37:177\u201393.","journal-title":"Clin. Pharmacokinet"},{"key":"1528_CR70","doi-asserted-by":"publisher","first-page":"415","DOI":"10.2165\/11587240-000000000-00000","volume":"50","author":"E Schwenger","year":"2011","unstructured":"Schwenger E, Dumontet J, Ensom MH. Does olanzapine warrant clinical pharmacokinetic monitoring in schizophrenia? Clin Pharmacokinet. 2011;50:415\u201328.","journal-title":"Clin Pharmacokinet"},{"key":"1528_CR71","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/nature01262","volume":"420","author":"C Mouse Genome Sequencing","year":"2002","unstructured":"Mouse Genome Sequencing C, Waterston RH, Lindblad-Toh K, Birney E, Rogers J, Abril JF, et al. Initial sequencing and comparative analysis of the mouse genome. Nature 2002;420:520\u201362.","journal-title":"Nature"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01528-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01528-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01528-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T13:30:18Z","timestamp":1669901418000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01528-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,22]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["1528"],"URL":"https:\/\/doi.org\/10.1038\/s41398-021-01528-y","relation":{},"ISSN":["2158-3188"],"issn-type":[{"type":"electronic","value":"2158-3188"}],"subject":[],"published":{"date-parts":[[2021,7,22]]},"assertion":[{"value":"9 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"405"}}